158 related articles for article (PubMed ID: 33745978)
1. The Impact of an Established Pharmaceutical Care Pathway on Drug Related Problems in an Intensive Care Unit.
Toukhy A; Fayed S; Sabry N; Shawki M
Am J Med Sci; 2021 Aug; 362(2):143-153. PubMed ID: 33745978
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
[TBL] [Abstract][Full Text] [Related]
3. Magnitude and determinants of drug-related problems among patients admitted to medical wards of southwestern Ethiopian hospitals: A multicenter prospective observational study.
Bekele F; Tsegaye T; Negash E; Fekadu G
PLoS One; 2021; 16(3):e0248575. PubMed ID: 33725022
[TBL] [Abstract][Full Text] [Related]
4. Handling drug-related problems in rehabilitation patients: a randomized study.
Willoch K; Blix HS; Pedersen-Bjergaard AM; Eek AK; Reikvam A
Int J Clin Pharm; 2012 Apr; 34(2):382-8. PubMed ID: 22388601
[TBL] [Abstract][Full Text] [Related]
5. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
6. Medication safety in a German telemedicine centre: Implementation of a telepharmaceutical expert consultation in addition to existing tele-intensive care unit services.
Amkreutz J; Lenssen R; Marx G; Deisz R; Eisert A
J Telemed Telecare; 2020; 26(1-2):105-112. PubMed ID: 30253681
[TBL] [Abstract][Full Text] [Related]
7. A multicenter quality improvement initiative on the impact of pharmacists' postdischarge follow-up to reduce medication-related acute care episodes.
Noh L; Heimerl K; Shane R
Am J Health Syst Pharm; 2020 Jun; 77(12):938-942. PubMed ID: 31960043
[TBL] [Abstract][Full Text] [Related]
8. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
9. Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.
Raimbault-Chupin M; Spiesser-Robelet L; Guir V; Annweiler C; Beauchet O; Clerc MA; Moal F
Int J Clin Pharm; 2013 Oct; 35(5):847-53. PubMed ID: 23857430
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China.
Chen Q; Jin Z; Zhang P; Sun S; Li L; Liao Y
Int J Clin Pharm; 2020 Aug; 42(4):1237-1241. PubMed ID: 32607718
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.
Ali MAS; Khedr EMH; Ahmed FAH; Mohamed NNE
Int J Clin Pharm; 2018 Oct; 40(5):1257-1264. PubMed ID: 29922968
[TBL] [Abstract][Full Text] [Related]
12. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study.
Ayhan YE; Karakurt S; Sancar M
J Clin Pharm Ther; 2022 Nov; 47(11):1867-1874. PubMed ID: 36196779
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial.
AbuRuz S; Jaber D; Basheti I; Sadeq A; Arafat M; AlAhmad M; Said A
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e72-e78. PubMed ID: 32661104
[TBL] [Abstract][Full Text] [Related]
14. Critical Care Pharmacists and Medication Management in an ICU Recovery Center.
Stollings JL; Bloom SL; Wang L; Ely EW; Jackson JC; Sevin CM
Ann Pharmacother; 2018 Aug; 52(8):713-723. PubMed ID: 29457491
[TBL] [Abstract][Full Text] [Related]
15. A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.
Kessemeier N; Meyn D; Hoeckel M; Reitze J; Culmsee C; Tryba M
Int J Clin Pharm; 2019 Oct; 41(5):1184-1192. PubMed ID: 31332648
[TBL] [Abstract][Full Text] [Related]
16. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
[TBL] [Abstract][Full Text] [Related]
17. Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study.
Stämpfli D; Boeni F; Gerber A; Bättig VAD; Weidmann R; Hersberger KE; Lampert ML
BMJ Open; 2018 Jun; 8(6):e021284. PubMed ID: 29950469
[TBL] [Abstract][Full Text] [Related]
18. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
19. In-hospital medication reviews reduce unidentified drug-related problems.
Bondesson A; Eriksson T; Kragh A; Holmdahl L; Midlöv P; Höglund P
Eur J Clin Pharmacol; 2013 Mar; 69(3):647-55. PubMed ID: 22955893
[TBL] [Abstract][Full Text] [Related]
20. Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China.
Liu P; Li G; Han M; Zhang C
BMC Pharmacol Toxicol; 2021 Oct; 22(1):65. PubMed ID: 34702348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
